| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/30/2003 | WO2002008245A3 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | US20030023071 DNA encoding proteins that inhibit Hsp70 function |
| 01/30/2003 | US20030023049 Site specific protein modification |
| 01/30/2003 | US20030023048 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 01/30/2003 | US20030023047 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
| 01/30/2003 | US20030023043 Changing a physicochemical property of a protein while having a desired property of the protein, and then separating and purifying the protein |
| 01/30/2003 | US20030023037 For use in analyte detection and analyte purification applications |
| 01/30/2003 | US20030022821 A modified lactoferrin peptide which is cytotoxic, 7 to 25 amino acids in length, with three or more cationic residues and has one or more extra bulky and lipophilic amino acids as compared to the native lactoferrin seuquence |
| 01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022285 Generation of preferential polypeptide with amplified immunogenicity; obtain preferential amino acid and nucleotide sequences, insert data into computer, screen for variant protein with amplified immunogenicity |
| 01/30/2003 | US20030021795 Administering antibody; determination binding to peptide |
| 01/30/2003 | CA2454418A1 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/30/2003 | CA2454226A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | CA2453987A1 Dolastatin 10 derivatives |
| 01/29/2003 | EP1279731A1 Process for the development of binding mini-proteins |
| 01/29/2003 | EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions |
| 01/29/2003 | EP1278853A2 Listeria monocytogenes genome, polypeptides and uses |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278772A2 Glucagon antagonists |
| 01/29/2003 | EP1278549A2 Cyclodextrin containing glycopeptide antibiotic compositions |
| 01/29/2003 | EP0754192B1 Circularly permuted ligands and circularly permuted chimeric molecules |
| 01/29/2003 | CN1393453A Activator protein for fibrin dissolving system |
| 01/28/2003 | USRE37971 Selective acylation of epsilon-amino groups |
| 01/28/2003 | US6512093 said fatty acids being chlorinated fatty acids of the olive oil. |
| 01/28/2003 | US6512092 Solid phase peptide synthesis; in situ generation of amino acid chloride by deblocking; coupling sterically hindered amino acid residues |
| 01/28/2003 | US6511962 Intermediates useful for synthesizing laspartomycin derivatives as well as the laspartomycin derivatives |
| 01/28/2003 | US6511823 Novel DNA and amino acid sequences; expression vectors and host cells useful in a method for production of the HBNF protein |
| 01/28/2003 | US6511803 Replica amplification of nucleic acid arrays |
| 01/23/2003 | WO2003006661A2 Transgenic plants expressing cobalamin binding proteins |
| 01/23/2003 | WO2003006505A1 Factor viii separation |
| 01/23/2003 | WO2003006501A2 G-csf conjugates |
| 01/23/2003 | WO2003006433A1 Protein modification reagents |
| 01/23/2003 | WO2003006154A2 Protein design automation for designing protein libraries with altered immunogenicity |
| 01/23/2003 | WO2003006044A1 Methods and compositions for controlling protein assembly or aggregation |
| 01/23/2003 | WO2002002607A3 Acid-modified arabinogalactan protein composition |
| 01/23/2003 | US20030018438 Binding compounds and methods for identifying binding compounds |
| 01/23/2003 | US20030018169 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 01/23/2003 | US20030018168 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018164 Automatic biosynthesis cycles |
| 01/23/2003 | US20030018163 Acylation, amidation; using amine scavenger |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017484 Arrays for detecting nucleic acids |
| 01/23/2003 | US20030015426 For conducting isoelectric focusing using immobilized pH gradient (IPG) strips; obviates the use of an occlusive oil layer, and allows vertical orientation; by hydratingly lodging a hydratable separation medium within an enclosure |
| 01/23/2003 | CA2453574A1 Transgenic plants expressing cobalamin binding proteins |
| 01/23/2003 | CA2453388A1 Factor viii separation |
| 01/23/2003 | CA2452824A1 Protein design automation for designing protein libraries with altered immunogenicity |
| 01/23/2003 | CA2452582A1 G-csf conjugates |
| 01/22/2003 | EP1277761A2 Process for the preparation of peptides |
| 01/22/2003 | EP1276770A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 01/22/2003 | EP1276759A2 Reductive alkylation process on glycopeptides |
| 01/22/2003 | EP1276758A2 A glycopeptide and preparation thereof |
| 01/22/2003 | EP1276716A2 Metal chelating compositions |
| 01/22/2003 | EP1276557A2 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface |
| 01/22/2003 | EP1222459A4 Crystallographic structure of the androgen receptor ligand binding domain |
| 01/22/2003 | EP0540651B1 Endogenously sweetened transgenic plant products |
| 01/22/2003 | CN1392877A Protein hydrolyzates, process for producing the same and drinks and foods containing protein hydrolyzates |
| 01/22/2003 | CN1392156A Synthesizing method for propyl-glutdipeptide |
| 01/22/2003 | CN1392155A Desalting and concentrating of oligopeptide solution by nano filtering technology |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/22/2003 | CN1099424C Catalytic circular preparation of fibroin peptide |
| 01/22/2003 | CN1099423C Human neuropeptide receptor |
| 01/21/2003 | US6509454 Free solution ligand interaction molecular separation method |
| 01/21/2003 | US6509453 Use of oil bodies and their associated proteins as affinity matrices for the separation and purification of target molecules from samples |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509173 Related members of a broad class of polypeptide mediators, which includes the interferons, interleukins and growth factors, collectively called cytokines |
| 01/16/2003 | WO2003005036A2 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004615A2 Secreted proteins |
| 01/16/2003 | WO2003003979A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | WO2003003838A1 Method of enhancing the extraction of proteinase inhibitors |
| 01/16/2003 | WO2002044327A3 Method and apparatus for protein manipulation |
| 01/16/2003 | WO2002031109A3 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2002002150A8 Stable radioiodine conjugates and methods for their synthesis |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | US20030013857 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties |
| 01/16/2003 | US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013649 Hybrid polypeptide |
| 01/16/2003 | US20030013641 Complexing drug with diketopiperazine; washing; separation of impurities |
| 01/16/2003 | US20030013188 Solid support for use in the chemical storage, synthesis and diagnostics |
| 01/16/2003 | US20030013160 In vito translation o proteins; obtain nucleotide sequences, incubate with reaction mixtures, translate, recover proteins |
| 01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
| 01/16/2003 | US20030012817 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 01/16/2003 | US20030010715 Use of cationic exchange chromatography on solid matrix carried out at basic pH |
| 01/16/2003 | US20030010620 Laser hydrolysis of polypeptides |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2452501A1 Secreted proteins |
| 01/16/2003 | CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | CA2450502A1 Epf receptor assays, compounds and therapeutic compositions |
| 01/15/2003 | EP1275004A2 Mass labels |
| 01/15/2003 | EP1274722A2 Purification of polypeptides |
| 01/15/2003 | EP1274721A1 Haemostatically active preparation containing vwf and method for the production thereof |
| 01/15/2003 | EP1147129A4 Saccharides linked to compounds that bind cell-surface peptides or proteins |
| 01/15/2003 | EP0833659A4 Therapeutic fragments of von willebrand factor |
| 01/15/2003 | CN1391580A Peptides |